Relationship Between Baseline Low-Density Lipoprotein Cholesterol and Percent Low-Density Lipoprotein Cholesterol Reduction With Evolocumab in the FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk) Trial

被引：0
|
作者：
Marcusa, Dan P.
Giugliano, Robert P.
Park, Jeong-Gun
Sever, Peter
Wang, Huei
Hamer, Andrew
Pedersen, Terje R.
Keech, Anthony C.
Sabatine, Marc S.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.13200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13200
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The Relationship Between Reduction in Low-Density Lipoprotein Cholesterol by Statins and Reduction in Risk of Cardiovascular Outcomes: An Updated Meta-Analysis
    Delahoy, Philippa J.
    Magliano, Dianna J.
    Webb, Kate
    Grobler, Mendel
    Liew, Danny
    CLINICAL THERAPEUTICS, 2009, 31 (02) : 236 - 244
  • [42] Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol
    deGoma, Emil M.
    Leeper, Nicholas J.
    Heidenreich, Paul A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 49 - 55
  • [43] Targeting Low-Density Lipoprotein Cholesterol in Cardiovascular Health
    Spratt, Kelly
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (04):
  • [44] Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
    Sharma, Rakesh K.
    Singh, Vibhuti N.
    Reddy, Hanumanth K.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 793 - 799
  • [45] COMPARISON OF CARDIOVASCULAR EVENTS BETWEEN PATIENTS ACHIEVING LOW-DENSITY LIPOPROTEIN PARTICLE TARGETS AND PATIENTS ACHIEVING LOW-DENSITY LIPOPROTEIN CHOLESTEROL TARGETS
    Jacobson, Terry A.
    Grabner, Michael
    Punekar, Rajeshwari
    Quimbo, Ralph A.
    Cziraky, Mark
    Winegar, Deborah
    Toth, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1462 - A1462
  • [46] Novel Therapies for Low-Density Lipoprotein Cholesterol Reduction
    Toth, Peter P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (06): : 19A - 32A
  • [47] Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets
    Toth, Peter P.
    Grabner, Michael
    Punekar, Rajeshwari S.
    Quimbo, Ralph A.
    Cziraky, Mark J.
    Jacobson, Terry A.
    ATHEROSCLEROSIS, 2014, 235 (02) : 585 - 591
  • [48] Potential low-density lipoprotein cholesterol, cardiovascular risk and costs reduction with evolocumab: a simulation in patients with a recent myocardial infarction in Spain
    Escobar-Cervantes, C.
    Fernandez-Delgado, M.
    Roldan, C.
    Sicras-Mainar, A.
    Villa, G.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2592 - 2592
  • [49] Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China
    Chen, Liang
    Chen, Shi
    Bai, Xueke
    Su, Mingming
    He, Linkang
    Li, Guangyu
    He, Guangda
    Yang, Yang
    Zhang, Xiaoyan
    Cui, Jianlan
    Xu, Wei
    Song, Lijuan
    Yang, Hao
    He, Wenyan
    Zhang, Yan
    Li, Xi
    Hu, Shengshou
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [50] Low low-density lipoprotein cholesterol and cancer risk - Reply
    Alsheikh-Ali, Alawi A.
    Karas, Richard H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 92 - 92
12345